title: Long-chain fatty acids and early visual and cognitive development of preterm infants.
abstract: Preterm infants fed formula supplemented with DHA were shown in two randomized, clinical trials to have improved visual acuity in the first half of infancy. In the second clinical trial, infants simultaneously supplemented with DHA and provided with a nutrient-enriched preterm formula had a higher Bayley MDI score at 12 months than controls fed preterm formula. These data are the first evidence that DHA alone can also improve performance on early tests of mental development. Because visual and behavioural development are improved by providing this single dietary compound, DHA appears to be conditionally essential for preterm infants. Nevertheless, we would like to insert a few words of caution. More information about long chain n-3 and n-6 fatty acid requirements and balance for developing human infants is needed. As formulas are designed to meet n-3 and n-6 fatty acid needs, controlled studies of biochemistry and function should continue.
authors.affiliation: Department of Pediatrics, University of Tennessee, Memphis 38163.
authors.forename: S E
authors.initials: SE
authors.lastname: Carlson
authors.forename: S H
authors.initials: SH
authors.lastname: Werkman
authors.forename: J M
authors.initials: JM
authors.lastname: Peeples
authors.forename: W M
authors.initials: WM
authors.lastname: Wilson
mesh_terms: D003071:Cognition / Q000187:drug effects*; D004281:Docosahexaenoic Acids / Q000494:pharmacology*; D015118:Eicosapentaenoic Acid / Q000494:pharmacology*; D006801:Humans; D018730:Infant Behavior / Q000187:drug effects; D007231:Infant, Newborn; D007234:Infant, Premature / Q000254:growth & development*; D011597:Psychomotor Performance / Q000187:drug effects; D016032:Randomized Controlled Trials as Topic; D014792:Visual Acuity / Q000187:drug effects*
chemical_list: D004281:Docosahexaenoic Acids; D015118:Eicosapentaenoic Acid